Bellbrook Names Cambio UK Distributor for Transcreener Products | GenomeWeb

NEW YORK (GenomeWeb News) – BellBrook Labs today announced a revised distribution agreement with Cambio to include BellBrook's full Transcreener product line of HTS assays.

Under the terms of the revised deal, Cambio becomes the exclusive distributor of BellBrook's Transcreener HTS assays in the UK. Cambio will also distribute BellBrook's new Transzyme product line of turnkey methyltransferase assay kits combining precalibrated purified methytransferase enzymes and substrates from Reaction Biology with BellBrook's Transcreener Epigen Methyltransferase detection reagents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.